Antti Koskenalho

Prostate Cancer Research

Papers

1

Total Citations

20

H-Index

1

About

Dr. Antti Koskenalho is a translational researcher whose work bridges molecular biology and surgical pathology, with a primary focus on prostate cancer diagnostics. His key contributions center on optimizing tissue preservation methods to enable high-fidelity integration of clinical, histomorphologic, and molecular data—a critical need for advancing cancer biology and precision medicine. In his most cited work, “Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology” (2017, 20 citations), Dr. Koskenalho systematically compared fresh frozen, formalin-fixed paraffin-embedded (FFPE), and PAXgene-fixed paraffin-embedded (PFPE) tissue preparations. This study demonstrated that PAXgene fixation preserves both morphological integrity and nucleic acid quality, offering a viable alternative to traditional FFPE for molecular research without compromising diagnostic utility. By validating a method that supports simultaneous pathological assessment and molecular analysis, his work has practical implications for biobanking, biomarker discovery, and the development of integrated diagnostic workflows. Though early in his citation impact, this foundational study positions Dr. Koskenalho as a methodologist whose technical innovations support the next generation of prostate cancer research and personalized diagnostics.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology
20 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Prostate Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago